Effects of losartan, somatostatin and losartan plus somatostatin on portal hemodynamics and renal functions in cirrhosis

Hulagu S. , Senturk O., Erdem A., Ozgur O., Celebi A., Karakaya A., ...More

HEPATO-GASTROENTEROLOGY, vol.49, no.45, pp.783-787, 2002 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 49 Issue: 45
  • Publication Date: 2002
  • Page Numbers: pp.783-787


Background/Aims: Several drugs have been used reduce, portal hypertension. Losartan constitutes arteriolar and venous Vasodilation by inhibiting the effects of the increased angiotensin II in cirrhotic patients. In this study, we analysed the effects of losartan, when used alone and when combined with somiatostatin, on portal and renal hemodynamics.